Clinical Trial Update: Prospective Study to Assess DES Re-endothelization in BMS Restenosis and De-novo Lesions

View source ↗

Summary

A completed prospective study evaluating drug-eluting stent re-endothelization in patients with bare-metal stent restenosis and de novo coronary lesions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• De Novo Atherosclerotic Coronary Lesions
• In-stent Restenosis
• Silent Myocardial Ischemia
• Stable Coronary Artery Disease

Drugs mentioned

• Drug-eluting stent (drug-eluting stent)

Snippet

Sponsor: S.M. Misericordia Hospital | Conditions: Stable Coronary Artery Disease, Silent Myocardial Ischemia | Status: COMPLETED